Impact Factor
Review Harnessing ultrasound-responsive technologies for precision periodontitis therapy: a perspective Full text PDF
Research Paper A dual CEST-fluorescent reporter enables cross-validated tracking of hematopoietic engraftment in deep bone marrow Full text PDF
Review Recent advances in CRISPR technologies for biomedical applications and disease treatment Full text PDF
Review Organelle-targeted precision cancer theranostics: From molecular design to NIR-II imaging Full text PDF
Research Paper Early micro- and nanoscale microglial responses to blood–brain barrier modulation by transcranial focused ultrasound Full text PDF
Research Paper ARG2 drives osteoblast senescence by repressing mitophagy via the IκB–NF-κB–TXN2 signaling axis: implications for age-associated osteoporosis Full text PDF
Issue 13; 2026
Founding Editor-in-Chief:
Prof. Xiaoyuan (Shawn) Chen, PhD
Profile
Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications.
- Theranostics is indexed by Science Citation Index (SCI) and MEDLINE. (Full index information)
- Full texts of articles in PubMed Central and Europe PMC. Abstracts in PubMed.
- (For NIH-funded researchers) Save time by submitting your paper to us - this journal is in full compliance with NIH Public Access Requirement.
Special Issue - Advanced Cell and Gene Therapy Strategies for Precision Treatment of Autoimmune Diseases. Theme issue editors: Weisheng Guo (Guangzhou Medical University), Xiaoyuan Chen (Shandong Cancer Hospital and Institute).
Modulation of the blood-brain barrier (BBB) using transcranial focused ultrasound with intravenous microbubbles (FUS) has progressed to clinical trials. Guided by magnetic resonance imaging (MRI), FUS significantly increases local BBB permeability for approximately 6-24 h in mice, with an ensuing mild inflammation. Microglia, as the immune cells of the brain, are stimulated by FUS-BBB modulation, although the timing and nature of their responses remain ...